IntroductionEarly changes in the normal functioning of the endothelium are key initiating factors in the development and progression of atherosclerosis and they are present well before the presentation of clinical symptoms. To date, there is a wide range of methods in use to assess endothelial function, each with its own advantages and limitations.1 For diagnostic purposes and for indications of progression and outcomes of disease, a methodology measuring a biomarker in the blood would be convenient. Measurement of mRNA levels could provide a good option as: (1) measurement of this parameter requires small amounts of blood and (2) real-time RT-PCR to measure mRNA is relatively straightforward and technically less challenging than techniques used to measure protein levels.Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a highly expressed multifunctional protein with diverse physiological functions and activities involved in glycolysis, transcriptional and posttranscriptional gene regulation, vesicular transport, receptor-mediated cell signaling, chromatin structure, and the maintenance of DNA integrity. GAPDH activity is regulated by many factors, one of them being nitric oxide (NO).2 NO synthesized and released from vascular endothelium is an important regulator of vascular tone.3 It has been reported that NO can either inhibit or activate GAPDH in different cell types. 4,5 As it is known that NO derived from the vascular endothelium targets blood cells, 6 it is possible that GAPDH activity could be regulated by endothelial NO. If so, then GAPDH activity in blood cells could be reflective of vascular endothelial NO production and thus indicative of endothelial function in physiological and pathophysiological conditions.Although there was no previous work to support our hypothesis, we decided to explore the potential link between vascular endothelial function and GAPDH mRNA level in the blood in healthy volunteers. We found that real-time RT-PCR Ct values of blood GAPDH correlate with vascular function in healthy subjects. This suggests that GAPDH mRNA level could be a potential biomarker of vascular endothelial function.
Subjects and Methods
SubjectsSeventy-five young healthy volunteers (41 males, 34 females) were recruited for the study. None of the subjects were smokers, used any medication, or had a history of any symptomatic vascular disease(s). Subject characteristics are shown in Table 1. The study was approved by the Tayside Committee on Medical Research Ethics and written informed consent was obtained from each subject before participation in the study. All subjects attended for one single visit lasting up to 3 hours during which a blood sample was taken and vascular function tests performed (see below). Vascular assessments were conducted in a blood flow laboratory at a temperature of 23°C after 10 minutes of acclimatization. Subjects were asked to refrain from food and drink for at least 2 hours beforehand and also to refrain from physical activity for 1 day before their visit.
RNA preparation and ...